inclusion criteria: 1. laboratory or clinically confirmed positive sars-cov-2 rtpcr test (androcov clinical scoring for covid-19 diagnosis1) within 7 days prior to randomization 2. ≥18 years old 3. laboratory confirmed positive sars-cov-2 rtpcr test within 7 days prior to randomization 4. clinical status on the covid-19 ordinal scale (defined in section 5.1) of 1 to 3 5. subject (or legally authorized representative) gives written informed consent prior to performing any study procedures 6. subject (or legally authorized representative) agree that subject will not participate in another covid-19 trial while participating in this study

inclusion criteria: 1. laboratory or clinically confirmed positive sars-cov-2 rtpcr test (androcov clinical scoring for covid-19 diagnosis1) within 7 days prior to randomization 2. ≥18 years old 3. laboratory confirmed positive sars-cov-2 rtpcr test within 7 days prior to randomization 4. clinical status on the covid-19 ordinal scale (defined in section 5.1) of 1 to 3 5. subject (or legally authorized representative) gives written informed consent prior to performing any study procedures 6. subject (or legally authorized representative) agree that subject will not participate in another covid-19 trial while participating in this study

inclusion criteria: laboratory or clinically confirmed positive sars-cov-2 rtpcr test (androcov clinical scoring for covid-19 diagnosis1) within 7 days prior to randomization ≥18 years old laboratory confirmed positive sars-cov-2 rtpcr test within 7 days prior to randomization clinical status on the covid-19 ordinal scale (defined in section 5.1) of 1 to 3 subject (or legally authorized representative) gives written informed consent prior to performing any study procedures subject (or legally authorized representative) agree that subject will not participate in another covid-19 trial while participating in this study

inclusion criteria: laboratory or clinically confirmed positive sars-cov-2 rtpcr test (androcov clinical scoring for covid-19 diagnosis1) within 7 days prior to randomization ≥18 years old laboratory confirmed positive sars-cov-2 rtpcr test within 7 days prior to randomization clinical status on the covid-19 ordinal scale (defined in section 5.1) of 1 to 3 subject (or legally authorized representative) gives written informed consent prior to performing any study procedures subject (or legally authorized representative) agree that subject will not participate in another covid-19 trial while participating in this study

inclusion criteria: 1. laboratory or clinically confirmed positive sars-cov-2 rtpcr test (androcov clinical scoring for covid-19 diagnosis1) within 7 days prior to randomization 2. ≥18 years old 3. laboratory confirmed positive sars-cov-2 rtpcr test within 7 days prior to randomization 4. clinical status on the covid-19 ordinal scale (defined in section 5.1) of 1 to 3 5. subject (or legally authorized representative) gives written informed consent prior to performing any study procedures 6. subject (or legally authorized representative) agree that subject will not participate in another covid-19 trial while participating in this study

inclusion criteria: 1. laboratory or clinically confirmed positive sars-cov-2 rtpcr test (androcov clinical scoring for covid-19 diagnosis1) within 7 days prior to randomization 2. ≥18 years old 3. laboratory confirmed positive sars-cov-2 rtpcr test within 7 days prior to randomization 4. clinical status on the covid-19 ordinal scale (defined in section 5.1) of 1 to 3 5. subject (or legally authorized representative) gives written informed consent prior to performing any study procedures 6. subject (or legally authorized representative) agree that subject will not participate in another covid-19 trial while participating in this study